51 results
8-K
EX-99.1
DMKPQ
DMK Pharmaceuticals Corp
14 Nov 23
DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
3:57pm
Rebranded company to DMK Pharmaceuticals and appointed inaugural, passionate and committed leadership team to execute on new strategy to reduce opioid … , the Company conducted a series of management changes to optimize its leadership structure and result in a more cost-effective, coordinated
8-K
DMKPQ
DMK Pharmaceuticals Corp
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm
to public, private equity backed, and start-up businesses. From 2000 to 2011, Mr. Cohen served in various leadership roles of increasing responsibility
DEFC14A
DMKPQ
DMK Pharmaceuticals Corp
12 Oct 23
Proxy in contested solicitation
4:22pm
of his extensive experience in the biopharmaceutical industry, leadership, business and scientific knowledge of the life science and pharmaceutical … . Prior to joining Amylin Pharmaceuticals, Inc., Ms. Reed held financial leadership roles at several biotechnology and telecommunications companies. Ms
PREC14A
DMKPQ
DMK Pharmaceuticals Corp
2 Oct 23
Preliminary proxy with contested solicitation
4:49pm
industry, leadership, business and scientific knowledge of the life science and pharmaceutical industries, including his service as a director … ., Ms. Reed held financial leadership roles at several biotechnology and telecommunications companies. Ms. Reed began her career with Price Waterhouse
FWP
DMKPQ
DMK Pharmaceuticals Corp
27 Jul 23
Free writing prospectus
6:08am
with DMK Pharmaceuticals New leadership (CEO) has brought a change in direction and strategy Lead commercial product and lead development program uniquely … these future applications
18 Merger with DMK New leadership, clinical - stage programs and library of novel small molecules Accelerating ZIMHI sales
8-K
EX-10.2
wurmpk6 bayw
26 May 23
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
4:25pm
8-K
38j2iaj1gn3db s0koy6
26 May 23
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
4:25pm
DEFA14A
n5zlkdbu
27 Apr 23
Additional proxy soliciting materials
4:26pm
DEFM14A
f32g ixi6
13 Apr 23
Proxy related to merger
4:52pm
DEFA14A
hiiqfei4en
21 Jul 22
Additional proxy soliciting materials
4:23pm
8-K
EX-10.1
psmeo hdckwwregc
26 May 22
Departure of Directors or Certain Officers
5:01pm
8-K
b0qso3dc8yn do38
26 May 22
Departure of Directors or Certain Officers
5:01pm
8-K
EX-99.1
pm6xu55a9535qi0s
18 May 22
Adamis Pharmaceuticals Announces Leadership Transition to Support New Phase of Innovation and Growth
7:53pm
8-K
EX-99.1
djudz25xts5au
24 Aug 21
Adamis Announces Appointment of David C. Benedicto as Chief Financial Officer and Other Events
5:06pm
PREC14A
6gash0ru
23 Jun 21
Preliminary proxy with contested solicitation
4:17pm